Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2579-2595
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2579
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2579
Ref. | Year | Cohort | Study | Results |
Aberra et al[22] | 2003 | UC and CD; 159 patients | Retrospective 1999-2000 | Increased post-operative infection; No increase observed when 6 MCP/AZP were used |
Nguyen et al[23] | 2014 | UC and CD; 15945 patients | Retrospective 2005-2012 | Increased post-operative infection |
Fumery et al[25] (REMIND group) | 2017 | CD; 209 patients | Prospective study 2010-2014 | Increased overall post-operative complications, intra- and extra-abdominal septic complications |
Subramanian et al[24] | 2008 | UC and CD | Meta-analysis; 7 studies | Increased infectious complications postoperatively and these increase with a dose of > 40 mg/day of corticosteroids |
Law et al[14] | 2020 | UC and CD | Meta-analysis; 35 studies | Increased infectious complications and intra-abdominal infections |
- Citation: Mowlah RK, Soldera J. Risk and management of post-operative infectious complications in inflammatory bowel disease: A systematic review. World J Gastrointest Surg 2023; 15(11): 2579-2595
- URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2579.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2579